Our research

With one in two predicted to get cancer in their lifetime, cancer is internationally agreed as one of the challenges of our time. Within the UK, cancer incidence in Liverpool is higher than in most comparable cities. Bringing together our excellent multidisciplinary research community, we aim to transform collaborative cancer research to benefit patients.

Cancer and COVID-19 Lab technician doing research with a microscope in the lab

Cancer and COVID-19

Liverpool researchers have come together to research the effects of COVID-19 on cancer patients. People with cancer are known to be more at risk of severe COVID-19. Research in Liverpool addresses which cancer patients are most vulnerable and which treatments carry the most risk.

Liverpool Experimental Cancer Medicine Centre ECMC logo

Liverpool Experimental Cancer Medicine Centre

The Liverpool ECMC, funded by CRUK and the NIHR, is a collaboration between the University of Liverpool and The Clatterbridge Cancer Centre NHS Foundation Trust.

Pancreatic and Hepatobiliary Doctor taking out medicine from the refrigerator with a disposable syringe

Liverpool Pancreatic and Hepatobiliary Research

We bring together our excellent clinical, translational and basic research under an overarching collaboration aiming to detect cancer early and improve life for those at risk or affected by pancreatic and hepatobiliary disease.

Haemato-oncology

Haemato-oncology

With our team science approach, we have established a programme of translational and clinical research in haemato-oncology. The recent reconfiguration of the clinical service enables us to take our research to the next level and bring even more benefit for our patients.

Liverpool Head and Neck Centre Liverpool Head and Neck Centre logo

Liverpool Head and Neck Centre

Head and neck cancer is a devastating disease and is a major healthcare problem in the Liverpool region. The Liverpool Head and Neck Centre (LHNC) combines internationally recognised clinical and research strengths to deliver research-led improvements in the quality and safety of patient care.

Immuno-oncology Natural Killer Cell (NK Cell) destroying a cancer cell

Immuno-oncology

Our overarching aim is the preclinical development and early phase clinical testing of strategies to induce anti-tumour immune responses in patients. With a strong collaborative approach, we are working with surgeons, oncologists and researchers across the region, nationally and internationally.

Molecular mechanisms of cancer progression

Molecular mechanisms of cancer progression

University of Liverpool researchers work with colleagues around the world to understand the mechanisms that underpin cancer development and progression that can be used as a target for drugs and therapies.

Ocular Oncology

.

Training and development

Training and Development

At the University of Liverpool, developing the future leaders in cancer research is a priority and we support our students and staff at all stages of their training and development with innovative approaches and unique infrastructure.